InflammaSense
CompanyUnited States
InflammaSense develops one asset, in human trials (VITALx-patch in critical illness). Mostly device acting on inflammation; based in the United States.
- 1
- Asset
- Furthest stage
- Human trials
- 0
- Trials
- 0
- Signals
Pipeline
1Wearable sensor monitoring autonomic and inflammatory signatures in critical care
Human trials, Device, Inflammation, critical illness
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms1
- Similar companies6